To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Topical Tranexamic Acid in Patients Undergoing Short Intramedullary Nailing for Hip Fractures

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
March 2022

Topical Tranexamic Acid in Patients Undergoing Short Intramedullary Nailing for Hip Fractures

Vol: 206| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Topical administration of tranexamic acid in elderly patients undergoing short femoral nailing for intertrochanteric fracture: A randomised controlled trial

Injury. 2022 Feb;53(2):603-609.

Contributing Authors:
DK Yee JSH Wong E Fang TM Wong C Fang F Leung

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and twenty one patients undergoing short intramedullary nailing for an intertrochanteric hip fracture were randomized to receive intraoperative topical tranexamic acid (TXA, n=61) or normal saline (n=60). The primary outcomes of interest were blood loss, drain output, transfusion rates and postoperative complications. There was no significant differences in total blood loss, drain outp...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue